McCully James D, Del Nido Pedro J, Emani Sitaram M
Department of Cardiac Surgery, Boston Children's Hospita, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Department of Cardiac Surgery, Boston Children's Hospita, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Mitochondrion. 2022 May;64:27-33. doi: 10.1016/j.mito.2022.02.007. Epub 2022 Feb 22.
Mitochondrial transplantation involves the replacement or augmentation of native mitochondria damaged, by ischemia, with viable, respiration-competent mitochondria isolated from non-ischemic tissue obtained from the patient's own body. The uptake and cellular functional integration of the transplanted mitochondria appears to occur in all cell types. Efficacy and safety have been demonstrated in cell culture, isolated perfused organ, in vivo large animal studies and in a first-human clinical study. Herein, we review our findings and provide insight for use in the treatment of organ ischemia- reperfusion injury.
线粒体移植涉及用从患者自身身体获取的非缺血组织中分离出的有活力、具备呼吸功能的线粒体,替换或补充因缺血而受损的天然线粒体。移植的线粒体似乎能被所有细胞类型摄取并在细胞功能上实现整合。在细胞培养、离体灌注器官、体内大型动物研究以及首例人体临床研究中均已证明了其有效性和安全性。在此,我们回顾我们的研究结果,并为器官缺血再灌注损伤的治疗提供见解。